Short Interest in Vivos Inc. (OTCMKTS:RDGL) Drops By 67.8%

Vivos Inc. (OTCMKTS:RDGL) was the recipient of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 5,800 shares, a drop of 67.8% from the January 31st total of 18,000 shares. Based on an average trading volume of 2,339,200 shares, the short-interest ratio is presently 0.0 days.

Vivos Stock Performance

OTCMKTS:RDGL traded down $0.00 during mid-day trading on Friday, hitting $0.11. 1,037,901 shares of the stock were exchanged, compared to its average volume of 1,362,140. The firm’s 50-day simple moving average is $0.13 and its 200 day simple moving average is $0.13. The stock has a market capitalization of $50.23 million, a price-to-earnings ratio of -11.07 and a beta of 0.89. Vivos has a fifty-two week low of $0.05 and a fifty-two week high of $0.26.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.